The abstract is read at the publisher; the summary is JClub's.
Type II Panoptes generates cyclic tri-adenylate (cA3) that keeps a CARF-TM effector in an inactive, dimeric state, and cA3 loss triggers membrane disruption and growth arrest.
- Why it matters: Viral cyclic-nucleotide sponges and phosphodiesterases can subvert cyclic second-messenger immunity, so guard mechanisms that resist these tactics are needed to understand robust anti-phage defence.
- What they did: The study characterizes type II Panoptes signalling, showing cA3 production and that CARF conformational changes occur when cA3 is sequestered or degraded, with in vivo effects assessed by cA3 absence.
- The result: In vivo, lacking cA3 causes membrane disruption and growth arrest, and defence against Acb1-expressing phages is linked to escapers mutating acb1 to evade activation.
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.